Hearing shines spotlight on biosimilar controversies.
Asher
A
Mullard
D000818:Animals; D001688:Biological Products / Q000493:pharmacokinetics / Q000592:standards*; D003226:Congresses as Topic / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D001688:Biological Products